Regarding T2DM medication, women who used glucose-lowering drugs (excluding insulin) had a significantly increased risk of invasive bladder with a multivariable-adjusted HR of 6.08 (95% CI 2.75–13.43), compared to women without T2DM. Here, INS is linked to type 2 diabetes mellitus.